Harvard study links GLP-1 weight-loss drugs to a 27-point jump in women's employment — bigger than a college degree gap
shutterstock.com / Pietukhova Pretty privilege may be alive and well. Apparently, so is skinny privilege. For years, economists have documented what they call the "obesity penalty" — the social and financial disadvantages people can face because of their weight. Now, the rise of GLP-1 medications is giving researchers a new way to measure just how much appearance may shape someone's economic prospects. Must Read Jeff Bezos backs a platform that lets any...
Read more at finance.yahoo.com